|
⚲
|
| Keyboard |
| Canaan Partners X LLC
✚
|
|
|---|---|
| CIK # | 0001673228 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| IDEAYA Biosciences Inc | 71.8 | ||
| Holdings by Sector ($M) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001673228] | |
| 3 | [0001673228] | |
| 4 | [0001673228] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Astra Space Inc | |
| Canaan Partners X LLC | |
| Canaan X LP | |
| Iterum Therapeutics Ltd | |
| IDEAYA Biosciences Inc | |
| NextCure Inc | |
| Protagonist Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Astra Space Inc ASTR
Class A Common Stock
|
2021-12-31 | Other | 4,200,000 | ||
|
Iterum Therapeutics Ltd ITRM
6.500% Exchangeable Senior Subordinated Note due 2025 · derivative
|
2020-01-21 | Grant | $2,000,000.00 | ||
|
IDEAYA Biosciences Inc IDYA
Series A Preferred Stock · derivative
|
2019-05-28 | Conversion | 1,658,164 | ||
|
IDEAYA Biosciences Inc IDYA
Common Stock
|
2019-05-28 | Conversion | 1,658,164 | ||
|
IDEAYA Biosciences Inc IDYA
Common Stock
|
2019-05-28 | Conversion | 602,549 | ||
|
IDEAYA Biosciences Inc IDYA
Common Stock
|
2019-05-28 | Buy | 400,000 | $10.00 | 4,000,000 |
|
IDEAYA Biosciences Inc IDYA
Series B Preferred Stock · derivative
|
2019-05-28 | Conversion | 602,549 | ||
|
NextCure Inc NXTC
Common Stock
|
2019-05-13 | Conversion | 743,110 | ||
|
NextCure Inc NXTC
Common Stock
|
2019-05-13 | Buy | 50,000 | $15.00 | 750,000 |
|
NextCure Inc NXTC
Common Stock
|
2019-05-13 | Conversion | 445,866 | ||
|
NextCure Inc NXTC
Common Stock
|
2019-05-13 | Conversion | 729,599 | ||
|
NextCure Inc NXTC
Common Stock
|
2019-05-13 | Conversion | 285,867 | ||
|
NextCure Inc NXTC
Series A-2 Preferred Stock · derivative
|
2019-05-13 | Conversion | 5,970,000 | ||
|
NextCure Inc NXTC
Series A-3 Preferred Stock · derivative
|
2019-05-13 | Conversion | 5,861,455 | ||
|
NextCure Inc NXTC
Series B-1 Preferred Stock · derivative
|
2019-05-13 | Conversion | 2,296,605 | ||
|
NextCure Inc NXTC
Series A-1 Preferred Stock · derivative
|
2019-05-13 | Conversion | 3,582,000 | ||
|
Iterum Therapeutics Ltd ITRM
Series A Preferred Shares · derivative
|
2018-05-30 | Conversion | 721,408 | $0.00 | |
|
Iterum Therapeutics Ltd ITRM
Series B-1 Preferred Shares · derivative
|
2018-05-30 | Conversion | 275,446 | $0.00 | |
|
Iterum Therapeutics Ltd ITRM
Ordinary Shares
|
2018-05-30 | Conversion | 275,446 | ||
|
Iterum Therapeutics Ltd ITRM
Ordinary Shares
|
2018-05-30 | Buy | 506,656 | $13.00 | 6,586,528 |
| showing 20 of 39 most recent transactions | |||||